{"database": "lobbying", "table": "lobbying_activities", "rows": [[1412557, "23dc5730-4ad0-4d9e-a20f-f4479501add5", "2A", "BROWN RUDNICK LLP", 287895, "HOSPIRA, INC.", 2013, "second_quarter", "PHA", "H.R. 486- relating to the compounding of drug products\nHouse Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2013-07-18T12:11:23.250000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1412557"], "units": {}, "query_ms": 0.42981805745512247, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}